Mamoor, S. (2025). Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80. Zenodo.
Cita Chicago Style (17a ed.)Mamoor, Shahan. Therapeutic Targeting in HER2+ Breast Cancer to Prevent and Treat CNS Disease: CD80. Zenodo, 2025.
Cita MLA (9a ed.)Mamoor, Shahan. Therapeutic Targeting in HER2+ Breast Cancer to Prevent and Treat CNS Disease: CD80. Zenodo, 2025.
Precaución: Estas citas no son 100% exactas.